23 related articles for article (PubMed ID: 38647021)
1. Four- and five-component molecular solids: crystal engineering strategies based on structural inequivalence.
Mir NA; Dubey R; Desiraju GR
IUCrJ; 2016 Mar; 3(Pt 2):96-101. PubMed ID: 27006772
[TBL] [Abstract][Full Text] [Related]
2. Cocrystallization with syringic acid presents a new opportunity for effectively reducing the hepatotoxicity of isoniazid.
Liu F; Jiang FB; Li YT; Liu RM; Wu ZY; Yan CW
Drug Dev Ind Pharm; 2020 Jun; 46(6):988-995. PubMed ID: 32366135
[No Abstract] [Full Text] [Related]
3. Cocrystals of 5-fluorocytosine. II. Coformers with variable hydrogen-bonding sites.
Tutughamiarso M; Egert E
Acta Crystallogr B; 2012 Aug; 68(Pt 4):444-52. PubMed ID: 22810914
[TBL] [Abstract][Full Text] [Related]
4. Cocrystals of 5-fluorocytosine. I. Coformers with fixed hydrogen-bonding sites.
Tutughamiarso M; Wagner G; Egert E
Acta Crystallogr B; 2012 Aug; 68(Pt 4):431-43. PubMed ID: 22810913
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of binding with the α-glucosidase in vitro and the evaluation on hypoglycemic effect in vivo: Cocrystals involving synergism of gallic acid and conformer.
Xue N; He B; Jia Y; Yang C; Wang J; Li M
Eur J Pharm Biopharm; 2020 Nov; 156():64-74. PubMed ID: 32890659
[TBL] [Abstract][Full Text] [Related]
6. Cocrystal formulations: A case study of topical formulations consisting of ferulic acid cocrystals.
Aitipamula S; Das S
Eur J Pharm Biopharm; 2020 Apr; 149():95-104. PubMed ID: 32035236
[TBL] [Abstract][Full Text] [Related]
7. Engineering Cocrystals of PoorlyWater-Soluble Drugs to Enhance Dissolution in Aqueous Medium.
Sathisaran I; Dalvi SV
Pharmaceutics; 2018 Jul; 10(3):. PubMed ID: 30065221
[TBL] [Abstract][Full Text] [Related]
8. Obtaining Cocrystals by Reaction Crystallization Method: Pharmaceutical Applications.
Biscaia IFB; Gomes SN; Bernardi LS; Oliveira PR
Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34204318
[TBL] [Abstract][Full Text] [Related]
9. Experimental cocrystal screening and solution based scale-up cocrystallization methods.
Malamatari M; Ross SA; Douroumis D; Velaga SP
Adv Drug Deliv Rev; 2017 Aug; 117():162-177. PubMed ID: 28811184
[TBL] [Abstract][Full Text] [Related]
10. Genetic and Epigenetic Regulation of the Innate Immune Response to Gout.
de Lima JD; de Paula AGP; Yuasa BS; de Souza Smanioto CC; da Cruz Silva MC; Dos Santos PI; Prado KB; Winter Boldt AB; Braga TT
Immunol Invest; 2023 Apr; 52(3):364-397. PubMed ID: 36745138
[TBL] [Abstract][Full Text] [Related]
11. Repurposing of Antifungal Drug Flucytosine/Flucytosine Cocrystals for Anticancer Activity against Prostate Cancer Targeting Apoptosis and Inflammatory Signaling Pathways.
Kanagavel M; Sparjan Samuvel RM; Ramalingam V; Nechipadappu SK
Mol Pharm; 2024 May; 21(5):2577-2589. PubMed ID: 38647021
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
